FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+34.9%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$3.13B
AUM Growth
+$3.13B
(+32%)
Cap. Flow
+$3.32M
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
99.84%
Holding
12
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
AXLA
Axcella Health Inc. Common Stock
AXLA
|
$3.32M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $2.31B | 73.9% | 12,886,743 | – | – |
|
|
OMGA
2
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $293M | 9.37% | 25,902,269 | – | – |
|
3
Sana Biotechnology
SANA
$777M
| $135M | 4.32% | 34,239,018 | – | – |
|
4
Seres Therapeutics
MCRB
$166M
| $129M | 4.13% | 23,117,045 | – | – |
|
|
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $81.2M | 2.59% | 50,427,328 | – | – |
|
6
Foghorn Therapeutics
FHTX
$286M
| $80.9M | 2.58% | 12,674,120 | – | – |
|
7
Denali Therapeutics
DNLI
$2.23B
| $72.9M | 2.33% | 2,619,968 | – | – |
|
|
AXLA
8
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $9.36M | 0.3% | 29,251,545 +10,383,760 | +55% | +$3.32M |
|
|
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
| $6.55M | 0.21% | 38,506,526 | – | – |
|
|
SGTX
10
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $3.63M | 0.12% | 10,370,369 | – | – |
|
|
SYRS
11
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.57M | 0.11% | 993,848 | – | – |
|
|
CDAK
12
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.38M | 0.04% | 3,540,636 | – | – |
|